Blood Test Identifies Acute Myeloid Leukemia Patients at Risk for Relapse
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read MorePosted by Andy Lundin | Mar 9, 2023 | Leukemia |
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read MorePosted by Andy Lundin | Mar 7, 2023 | Molecular Diagnostics |
Research on the genetics of cerebral palsy offers evidence that genetic testing should be offered as standard for people with the disorder.
Read MorePosted by Andy Lundin | Mar 6, 2023 | Cancer |
Invitae’s personalized cancer monitoring assay for MRD obtained its first commercial coverage in solid tumors by Blue Shield of California.
Read MorePosted by Andy Lundin | Mar 3, 2023 | Lab Automation, Molecular Diagnostics |
Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read MorePosted by Andy Lundin | Mar 2, 2023 | Cancer |
Investigators at Children’s Hospital Los Angeles investigators have developed a liquid biopsy for pediatric solid tumors.
Read More